Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas

Survival Analysis of High-Intensity Focused Ultrasound Therapy Versus Radiofrequency Ablation in the Treatment of Recurrent Hepatocellular Carcinoma

(2013) Albert C.Y. Chan et al.   ANNALS OF SURGERY

High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation

(2012) Tan To Cheung et al.   Hepatobiliary & Pancreatic Diseases International

Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

(2012) Young-Hwa Chung et al.   INTERNATIONAL JOURNAL OF CANCER

Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

(2012) Myeong Jun Song et al.   JOURNAL OF HEPATOLOGY

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

(2012) Jordi Bruix et al.   JOURNAL OF HEPATOLOGY

Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey

(2012) Kiyoshi Hasegawa et al.   JOURNAL OF HEPATOLOGY

The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma

(2012) Jia-Xin Li et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Deceased donation in Asia: Challenges and opportunities

(2012) Chung-Mau Lo   LIVER TRANSPLANTATION

Tolerance of High-Intensity Focused Ultrasound Ablation in Patients with Hepatocellular Carcinoma

(2012) Tan To Cheung et al.   WORLD JOURNAL OF SURGERY

Survival analysis of high‐intensity focused ultrasound ablation in patients with small hepatocellular carcinoma

(2012) Tan To Cheung et al.   HPB

High-Intensity Focused Ultrasound for Hepatocellular Carcinoma

(2011) Kelvin K.C. Ng et al.   ANNALS OF SURGERY

Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria

(2011) S. T. Fan et al.   BRITISH JOURNAL OF SURGERY

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

(2011) Massimo Iavarone et al.   HEPATOLOGY

High-intensity focused ultrasound as a treatment for colorectal liver metastasis in difficult position

(2011) Tan To Cheung et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Chemoembolization for intermediate HCC: Is there proof of survival benefit?

(2011) Alejandro Forner et al.   JOURNAL OF HEPATOLOGY

Continuous Sunitinib Treatment in Patients with Advanced Hepatocellular Carcinoma: A Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) Multicenter Phase II Trial (SAKK 77/06)

(2010) D. Koeberle et al.   ONCOLOGIST

The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization

(2009) Thomas Yau et al.   CANCER

Toward 300 liver transplants a year

(2009) Sung Gyu Lee et al.   SURGERY TODAY

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)

(2008) M. Doffoël et al.   EUROPEAN JOURNAL OF CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER